Replies to post #93668 on Anavex Life Sciences Corp (AVXL)

[baltimorebullet]

Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson’s disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010.[1]
In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million.

[kevindenver]

CYNA was the NASDAQ symbol and was bought out for $625 Million.

http://www.businesswire.com/news/home/20160831006494/en/Sunovion-Pharmaceuticals-Acquire-Cynapsus-Therapeutics

What's AVXL's market cap? Think it through IF the drug works.